Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $71.80 | $17.84 | 302.51% | 299.17x | 21.02x | 21.94x | 58.81x | 1.47x | $41.15M | 0.65% | $108.58M | 1.23 | $6.34B | 118.42 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.88 | $2.95 | 132.87% | 98.29x | 64.24x | 3.73x | 91.29x | 0.90x | $47.52M | 4.06% | $13.01M | 0.08 | $1.33B | 24.98 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $287.80 | $94.47 | 204.65% | 66.01x | 38.16x | 8.92x | 35.73x | 1.37x | $641.34M | 1.68% | $1.08B | 8.09 | $39.68B | 42.93 | ||
| CORT | CORCEPT THERAPEUTICS INC | $83.12 | $20.96 | 296.59% | 180.70x | 158.75x | 11.29x | 13.99x | 1.52x | $119.79M | 1.38% | $637.99M | 6.11 | $8.82B | -1,285.17 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.28 | $72.06 | -1.09% | 24.08x | 8.60x | 5.58x | 38.49x | 0.43x | $667.65M | 7.93% | $219.64M | 1.86 | $10.29B | 16.49 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $52.34 | $17.50 | 199.13% | 53.41x | 41.00x | 5.31x | 6.65x | 1.45x | $164.23M | 4.10% | $605.69M | 7.92 | $3.85B | 34.50 | ||
| KRYS | KRYSTAL BIOTECH INC | $324.75 | $96.35 | 237.04% | 41.90x | 40.84x | 22.79x | 7.50x | 2.00x | $237.38M | 2.50% | $1.28B | 43.59 | $9.08B | 42.44 | ||
| VCEL | VERICEL CORP | $38.29 | $9.23 | 314.88% | 89.05x | 79.42x | 6.66x | 5.49x | 1.87x | $47.49M | 2.44% | $356.23M | 7.02 | $1.94B | 48.01 | ||
| ASND | ASCENDIS PHARMA A | $223.29 | $81.51 | 173.93% | 23.67x | 14.97x | 13.62x | 24.16x | 2.42x | $52.94M | 0.38% | $574.09M | 9.24 | $14.25B | 152.81 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.65 | $42.20 | 31.86% | 39.75x | 14.67x | 3.30x | 1.73x | 0.54x | $767.06M | 7.16% | $6.21B | 32.27 | $9.11B | 18.89 | ||
| RPRX | ROYALTY PHARMA PLC | $54.27 | $40.29 | 34.70% | 28.41x | 10.18x | 9.71x | 3.14x | 0.61x | $2.34B | 9.87% | $9.94B | 22.75 | $39.62B | 34.06 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.55 | $16.13 | -22.19% | 6.12x | 26.18x | 5.99x | 3.60x | 0.82x | $56.42M | 7.70% | $205.80M | 3.52 | $647.45M | 4.48 | ||
| ADMA | ADMA BIOLOGICS INC | $8.50 | $9.79 | -13.15% | 12.32x | 9.29x | 3.94x | 5.05x | 0.47x | $107.90M | 5.38% | $390.33M | 1.65 | $2.03B | 9.16 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $230.59 | $49.90 | 362.07% | 490.62x | 8.96x | 3.22x | 3.19x | 1.65x | $1.30B | 9.09% | $4.53B | 73.22 | $18.03B | 26.70 | ||
| TECH | BIO-TECHNE CORP | $56.17 | $15.47 | 262.98% | 79.11x | 28.63x | 7.25x | 4.22x | 1.63x | $269.60M | 3.07% | $2.09B | 13.34 | $8.87B | 34.67 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.91 | $5.79 | -49.77% | 10.78x | 4.26x | 2.72x | 3.18x | 0.23x | $7.24M | 4.33% | $52.93M | 0.92 | $114.84M | 7.41 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $253.25 | $95.34 | 165.62% | 32.06x | 27.90x | 18.34x | 5.09x | 1.61x | $122.22M | 2.43% | $997.32M | 50.16 | $5.41B | 24.00 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.18 | $36.11 | -5.34% | 13.51x | 9.29x | 2.20x | 2.17x | 0.51x | $341.79M | 17.29% | $910.35M | 15.75 | $1.55B | 6.53 | ||
| TGTX | TG THERAPEUTICS INC | $50.30 | $17.21 | 192.31% | 15.62x | 35.96x | 10.37x | 13.20x | 247.53x | -$14.19M | -0.19% | $583.13M | 4.04 | $8.01B | 53.39 | ||
| UTHR | UNITED THERAPEUTICS CORP | $549.57 | $245.70 | 123.67% | 18.77x | 19.32x | 7.54x | 3.95x | 2.08x | $1.02B | 4.25% | $5.90B | 135.66 | $22.05B | 12.87 | ||
| EXEL | EXELIXIS INC | $53.00 | $31.16 | 70.10% | 16.99x | 16.09x | 5.76x | 6.88x | 1.24x | $917.69M | 6.70% | $1.94B | 7.49 | $13.27B | 12.56 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.52 | $2.48 | 41.68% | 14.67x | 14.88x | 2.16x | 3.41x | 0.99x | $4.11M | 1.45% | $82.33M | 1.03 | $216.38M | 10.19 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.06 | $1.27 | 61.83% | 10.84x | 9.48x | 2.15x | 2.47x | 2.67x | $13.00M | 7.91% | $67.23M | 0.84 | $132.75M | 5.95 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $614.98 | $440.40 | 39.64% | 14.45x | 13.07x | 4.29x | 2.05x | 0.98x | $4.11B | 6.43% | $31.42B | 302.15 | $64.22B | 11.18 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $450.46 | $169.63 | 165.55% | 26.48x | 23.04x | 9.37x | 5.90x | 1.93x | $3.71B | 3.24% | $19.36B | 76.20 | $110.82B | 20.55 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.37 | $12.37 | 153.57% | 17.33x | 16.00x | 6.42x | 3.79x | 3.89x | $208.13M | 5.43% | $1.01B | 8.28 | $3.09B | 9.21 | ||
| VCYT | VERACYTE INC | $49.15 | $7.68 | 540.21% | 44.28x | 44.07x | 7.22x | 2.92x | 9.43x | $155.34M | 3.97% | $1.34B | 16.90 | $3.70B | 32.13 | ||
| INCY | INCYTE CORP | $101.98 | $67.54 | 51.00% | 13.99x | 13.02x | 3.79x | 3.62x | 1.20x | $1.45B | 7.14% | $5.62B | 28.21 | $16.94B | 9.06 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $15.77 | $3.64 | 332.81% | 26.28x | 4.30x | 0.76x | 1.11x | 11.89x | $109.24M | 6.59% | $1.51B | 14.34 | $2.24B | 27.04 | ||
| MDXG | MIMEDX GROUP INC | $3.68 | $1.27 | 190.30% | 17.52x | -43.71x | 1.40x | 2.26x | 8.33x | $69.36M | 12.69% | $242.94M | 1.64 | $405.94M | 7.45 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.